KRAS mutant allele-specific imbalance has been reported to correlate with progression to undifferentiated carcinoma of the pancreas [19], and expression of granulocyte/macrophage colony stimulating factor (GM-CSF) to correlate with KRAS mutations in pancreatic tumors [20]. This evidence concerns the gene KRAS and pancreatic neoplasm.